NS · Pharmaceuticals

Granules India Ltd (GRANULES)

Pharmaceuticals & Biotechnology

Granules India Ltd (GRANULES) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $194.52B, P/E ratio is 48.55, net margin is 11.1%, dividend yield is 0.22%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for GRANULES

Market cap

$194.52B

P/E ratio

48.55

Net margin

11.1%

Dividend yield

0.22%

Granules India Ltd (GRANULES) — FAQ

What is Granules India Ltd's market cap?

Granules India Ltd (GRANULES) has a reported market cap of $194.52B (data as of 2026-07-10).

What is GRANULES's P/E ratio?

The price-to-earnings (P/E) ratio for Granules India Ltd (GRANULES) is 48.55 (data as of 2026-07-10).

Does Granules India Ltd pay a dividend?

Granules India Ltd (GRANULES) shows a reported dividend yield of 0.22%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is Granules India Ltd in?

Granules India Ltd (GRANULES) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).

What exchange is GRANULES listed on?

GRANULES is listed on NS.

What is Granules India Ltd's net margin?

Granules India Ltd (GRANULES) reports a net margin of 11.1% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Pharmaceuticals companies

FDC Ltd (FDC) Strides Pharma Science Ltd (STAR)